medigraphic.com
ISSN 0035-0052 (Print)

2020, Number 5

Next >>

Rev Mex Pediatr 2020; 87 (5)

Face masks use as a preventive measure in the context of the SARS-CoV-2 pandemic

Montaño-Luna VE, Miranda-Novales MG

Language: Spanish
References: 38
Page: 163-169
PDF size: 253.17 Kb.





REFERENCES

  1. World Health Organization. Coronavirus disease (COVID-19). Weekly Epidemiological Update, Available in: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20201012-weekly-epi-update-9.pdf.

  2. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91: 264-266. doi: 10.1016/j.ijid.2020.01.009.

  3. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019; 17(3): 181-192. doi: 10.1038/s41579-018-0118-9.

  4. Jiang S, Du L, Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infect. 2020; 9(1): 275-277. doi: 10.1080/22221751.2020.1723441.

  5. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223): 514-523. doi: 10.1016/S0140-6736(20)30154-9.

  6. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507-513. doi: 10.1016/S0140-6736(20)30211-7

  7. Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020; 12(2): 135. doi: 10.3390/v12020135.

  8. Gorbaleny AE, Baker SC, Baric RS, De Groot RJ, Drosten C, Gulyaeva C et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5: 536-544. doi: org/10.1038/s41564-020-0695-z.

  9. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506.

  10. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-1069. doi: 10.1001/jama.2020.1585.

  11. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al; China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-1720. doi: 10.1056/NEJMoa2002032.

  12. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 Infection in Children. N Engl J Med. 2020; 382(17): 1663-1665. doi: 10.1056/NEJMc2005073.

  13. Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A, Nocerino A et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020; 179(7): 1029-1046. doi: 10.1007/s00431-020-03684-7.

  14. Cheng VC, Wong SC, Chen JH, Yip CC, Chuang VW, Tsang OT et al. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol. 2020; 41(5): 493-498.

  15. Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020; 323(16): 1610-1612. doi:10.1001/jama.2020.3227.

  16. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). Appendices. [Access 25 October 2020] Available in: https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/appendix.html#contact.

  17. Siegel JD, Rhinehart E, Jackson M, Chiarello L; the Healthcare Infection Control Practices Advisory Committee. 2007 Guidelines for isolation precautions: preventing transmission of infectious agents in healthcare settings. Am J Infect Control. 2007; 35(Suppl 2): S65-S164.

  18. Jones RM, Brosseau LM. Aerosol transmission of infectious disease. J Occup Environ Med. 2015; 57(5): 501-508. doi: 10.1097/JOM.0000000000000448.

  19. Johnson GR, Morawksa L, Ristovski ZD, Hargreaves M, Mengersen K, Chao CY et al. Modality of human expired aerosol size distributions. J Aerosol Sci. 2011; 42: 839-851.

  20. Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020; 382(16): 1564-1567.

  21. Fears A, Klimstra W, Duprex P, Hartman A, Weaver SC, Plante KS et al. Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions. MedRxiv. [preprint]. [Access 22 October 2020] Available in: https://www.medrxiv.org/content/10.1101/2020.04.13.20063784v1.full.pdf+html.

  22. Yu P, Zhu J, Zhang Z, Han Y. A Familial Cluster of Infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. J Infect Dis. 2020; 221(11): 1757-1761.

  23. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020; 172(9): 577-582.

  24. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, Shaman J. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020; 368(6490): 489-493. doi: 10.1126/science.abb3221.

  25. Canini L, Andreoletti L, Ferrari P, D’Angelo R, Blanchon T, Lemaitre M et al. Surgical mask to prevent influenza transmission in households: a cluster randomized trial. PLoS One. 2010; 5(11): e13998.

  26. MacIntyre CR, Zhang Y, Chughtai AA, Seale H, Zhang D, Chu Y et al. Cluster randomised controlled trial to examine medical mask use as source control for people with respiratory illness. BMJ Open. 2016; 6(12): e012330.

  27. European Standards. UNE EN 14683:2019+AC:2019. Medical Face Masks -Requirements and Test Methods. 2019. [Access 23 October 2020] Available in: https://www.en-standard.eu/une-en-14683-2019-ac- 2019-medical-face-masks-requirements-and-test-methods/.

  28. F23 Committee, n.d. Specification for Performance of Materials Used in Medical Face Masks. ASTM International. Available in: https://doi.org/10.1520/F2100-19E01 (Access 9 October 2020).

  29. National Institute for Occupational Safety and Health (NIOSH). NIOSH Guide to the Selection and Use of Particulate Respirators. Department of Health and Human Services (DHHS) NIOSH publication number 96- 101, 1996. [Access 20 October 2020] Available in: http://www.cdc.gov/niosh/userguid.html.

  30. Centers for Disease Control and Prevention. Considerations for Wearing Masks. Help Slow de Spread of COVID-19. [Access 23 October 2020] Available in: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover-guidance.html.

  31. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). Personal Protective Equipment FAQs. [Access 23 October 2020] Available in: https://www.cdc.gov/coronavirus/2019-ncov/hcp/respirator-use-faq.html.

  32. Verma S, Dhanak M, Frankenfield J. Visualizing droplet dispersal for face shields and masks with exhalation valves. Phys Fluids. 2020; 32(9): 091701. doi: 10.1063/5.0022968.

  33. Jung H, Kim JK, Lee S, Lee J, Kim J, Tsai P et al. Comparison of filtration efficiency and pressure drop in anti-yellow sand masks, quarantine masks, medical masks, general masks, and handkerchiefs. Aerosol Air Qual Res. 2014;14, 991–1002. doi.org/10.4209/aaqr.2013.06.0201.

  34. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ. COVID-19 systematic urgent review group effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020; 395 (10242): 1973-1987. doi: 10.1016/S0140-6736(20)31142-9.

  35. Asadi S, Cappa CD, Barreda S, Wexler AS, Bouvier NM, Ristenpart WD. Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities. Sci Rep. 2020; 10: 15665. doi:10.1038/s41598-020-72798-7.

  36. World Health Organization. Advice on the use of masks in the context of COVID-19. [Access 23 October 2020] Available in: https://apps.who.int/iris/bitstream/handle/10665/332293/WHO-2019-nCov-IPC_Masks-2020.4-eng.pdf?sequence=1&isAllowed=y.

  37. Uchida M, Kaneko M, Hidaka Y, Yamamoto H, Honda T, Takeuchi S et al. Effectiveness of vaccination and wearing masks on seasonal influenza in Matsumoto City, Japan, in the 2014/2015 season: an observational study among all elementary schoolchildren. Prev Med Rep. 2017; 5: 86-91. Epub 2016/12/17.

  38. World Health Organization. Advice on the use of masks for children in the community in the context of COVID-19. Available in: https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC_Masks-Children-2020.1.




2020     |     www.medigraphic.com